Trials / Conditions / Veno-occlusive Disease

Veno-occlusive Disease

9 registered clinical trials studyying Veno-occlusive Disease — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Ketorolac for Acute Vaso-Occlusive Crisis in Pediatric Sickle Cell Disease NCT06579703	Children's Blood and Cancer Center at Dell Children's Medical Center	Phase 4
Recruiting	Defibrotide Dose-escalation for SOS Post-HSCT NCT05987124	New York Medical College	Phase 2
Unknown	5-day Defibrotide Treatment for Hepatic SOS/VOD NCT04313036	Loyola University	Phase 2
Terminated	Ultrasound Elastography to Predict Development of SOS NCT03858530	Children's Mercy Hospital Kansas City	N/A
Completed	Study Comparing Efficacy and Safety of Defibrotide vs Best Supportive Care in the Prevention of Hepatic Veno-O NCT02851407	Jazz Pharmaceuticals	Phase 3
Unknown	Pharmacokinetic Study of Lipo-PGE1 for Prevention of VOD After HSCT NCT02338440	Seoul National University Hospital	Phase 2 / Phase 3
Completed	Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter NCT00006083	Jonsson Comprehensive Cancer Center	Phase 3
Completed	Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation NCT00003966	Dana-Farber Cancer Institute	Phase 2
Completed	Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Pr NCT00003674	Alliance for Clinical Trials in Oncology	Phase 3